Clinical Study Evaluating Outcomes of Reverse Shoulder Arthroplasty With SMR Stemless

NCT04529798 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2024-07-31

No results posted yet for this study

Summary

The objectives of this study are the assessment of the clinical, radiographical and patient-reported outcomes of SMR Stemless Reverse Shoulder Arthroplasty (LimaCorporate S.p.A.) used as standard of care over a period of at least 2 years of follow-up and the evaluation of the incidence of any complication.

Conditions

  • Rotator Cuff Tear Arthropathy
  • Osteo Arthritis Shoulders

Sponsors & Collaborators

  • Arthro Medics AG

    lead OTHER

Principal Investigators

  • Claudio Rosso, Prof. Dr. med. · Arthro Medics AG

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-22
Primary Completion
2024-08-30
Completion
2025-08-30

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04529798 on ClinicalTrials.gov